APA
Dolzhikova I. V., Zubkova O. V., Tukhvatulin A. I., Dzharullaeva A. S., Tukhvatulina N. M., Shcheblyakov D. V., Shmarov M. M., Tokarskaya E. A., Simakova Y. V., Egorova D. A., Scherbinin D. N., Tutykhina I. L., Lysenko A. A., Kostarnoy A. V., Gancheva P. G., Ozharovskaya T. A., Belugin B. V., Kolobukhina L. V., Pantyukhov V. B., Syromyatnikova S. I., Shatokhina I. V., Sizikova T. V., Rumyantseva I. G., Andrus A. F., Boyarskaya N. V., Voytyuk A. N., Babira V. F., Volchikhina S. V., Kutaev D. A., Bel'skih A. N., Zhdanov K. V., Zakharenko S. M., Borisevich S. V., Logunov D. Y., Naroditsky B. S. & Gintsburg A. L. (20171024). Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia. : Human vaccines & immunotherapeutics.
Chicago
Dolzhikova I V, Zubkova O V, Tukhvatulin A I, Dzharullaeva A S, Tukhvatulina N M, Shcheblyakov D V, Shmarov M M, Tokarskaya E A, Simakova Y V, Egorova D A, Scherbinin D N, Tutykhina I L, Lysenko A A, Kostarnoy A V, Gancheva P G, Ozharovskaya T A, Belugin B V, Kolobukhina L V, Pantyukhov V B, Syromyatnikova S I, Shatokhina I V, Sizikova T V, Rumyantseva I G, Andrus A F, Boyarskaya N V, Voytyuk A N, Babira V F, Volchikhina S V, Kutaev D A, Bel'skih A N, Zhdanov K V, Zakharenko S M, Borisevich S V, Logunov D Y, Naroditsky B S and Gintsburg A L. 20171024. Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia. : Human vaccines & immunotherapeutics.
Harvard
Dolzhikova I. V., Zubkova O. V., Tukhvatulin A. I., Dzharullaeva A. S., Tukhvatulina N. M., Shcheblyakov D. V., Shmarov M. M., Tokarskaya E. A., Simakova Y. V., Egorova D. A., Scherbinin D. N., Tutykhina I. L., Lysenko A. A., Kostarnoy A. V., Gancheva P. G., Ozharovskaya T. A., Belugin B. V., Kolobukhina L. V., Pantyukhov V. B., Syromyatnikova S. I., Shatokhina I. V., Sizikova T. V., Rumyantseva I. G., Andrus A. F., Boyarskaya N. V., Voytyuk A. N., Babira V. F., Volchikhina S. V., Kutaev D. A., Bel'skih A. N., Zhdanov K. V., Zakharenko S. M., Borisevich S. V., Logunov D. Y., Naroditsky B. S. and Gintsburg A. L. (20171024). Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia. : Human vaccines & immunotherapeutics.
MLA
Dolzhikova I V, Zubkova O V, Tukhvatulin A I, Dzharullaeva A S, Tukhvatulina N M, Shcheblyakov D V, Shmarov M M, Tokarskaya E A, Simakova Y V, Egorova D A, Scherbinin D N, Tutykhina I L, Lysenko A A, Kostarnoy A V, Gancheva P G, Ozharovskaya T A, Belugin B V, Kolobukhina L V, Pantyukhov V B, Syromyatnikova S I, Shatokhina I V, Sizikova T V, Rumyantseva I G, Andrus A F, Boyarskaya N V, Voytyuk A N, Babira V F, Volchikhina S V, Kutaev D A, Bel'skih A N, Zhdanov K V, Zakharenko S M, Borisevich S V, Logunov D Y, Naroditsky B S and Gintsburg A L. Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia. : Human vaccines & immunotherapeutics. 20171024.